ProKidney Corp.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: ProKidney Corp.
Former names: Social Capital Suvretta Holdings Corp. III
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation: Cayman Islands
Headquarters city: Winston-Salem
Headquarters state / province: North Carolina
Headquarters country: United States
Fiscal year end: December
Ticker symbol: PROK
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001850270
EIN: 98-1586514

Board of directors

Follow this board

Alan Lotvin · Director
Since 2023
Brian Jg Pereira · Director
Since 2023
Bruce Culleton · Director · Chief Executive Officer
Since 2023
Jennifer A. Fox · Director
Since 2023
John Maraganore · Director Overboarded
Since 2023
Pablo G. Legorreta · Director
Since 2023
Santos Jose Ignacio Jimenez · Director
Since 2023
Timothy Bertram · Director · Chief Executive Officer
Since 2023
Uma Sinha · Director
Since 2023
William F. Doyle · Director
Since 2023

Chief executives

Timothy Bertram · Chief Executive Officer

Dates unknown

Bruce Culleton · Chief Executive Officer

Dates unknown

Director election results

Annual meeting of May 28, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

3 of this board's directors also sit on 10 other boards. 10 are in the same sector.

Shared director Other board Same sector

Agios Pharmaceuticals Inc. Same sector
via John Maraganore
Beam Therapeutics Inc. Same sector
via John Maraganore
City Therapeutics Inc. Same sector
via John Maraganore
Elanco Animal Health Incorporated Same sector
via William F. Doyle
Hemab Therapeutics Holdings Inc. Same sector
via John Maraganore
Kymera Therapeutics Inc. Same sector
via John Maraganore
NovoCure Limited Same sector
via William F. Doyle
Rapport Therapeutics Inc. Same sector
via John Maraganore
Royalty Pharma plc Same sector
via Pablo G. Legorreta
Takeda Pharmaceutical Company Limited Same sector
via John Maraganore

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $2,951,048; 10 sales by 1 insider

Date	Insider	Transaction	Shares	Price	Value
Oct 28, 2026	Weber Darin J. Officer (Chief Regulatory Officer)	Derivative conversion	+200,000	—	—
Aug 20, 2026	Brian Jg Pereira Director	Open-market sale	−222,948	$1.42	$316,586
Aug 20, 2026	Brian Jg Pereira Director	Open-market sale	−27,052	$1.42	$38,414
Aug 19, 2026	Brian Jg Pereira Director	Open-market sale	−222,949	$1.44	$321,047
Aug 19, 2026	Brian Jg Pereira Director	Open-market sale	−27,051	$1.44	$38,953
Aug 18, 2026	Brian Jg Pereira Director	Open-market sale	−229,338	$1.37	$314,193
Aug 18, 2026	Brian Jg Pereira Director	Open-market sale	−27,826	$1.37	$38,122
Aug 4, 2026	Brian Jg Pereira Director	Derivative conversion	+81,929	—	—
Aug 4, 2026	Brian Jg Pereira Director	Derivative conversion	+675,235	—	—
Jun 12, 2026	Girolamo Todd C Officer (Chief Legal Officer)	Derivative conversion	+163,857	—	—
Apr 28, 2026	Control Empresarial de Capitales S.A. de C.V. 10% owner, Add'l Rep. Persons-see Ex.99-1	Derivative conversion	+63,118,645	—	—
Nov 13, 2025	Brian Jg Pereira Director	Open-market sale	−447,803	$2.37	$1,061,293
Nov 13, 2025	Brian Jg Pereira Director	Open-market sale	−54,333	$2.37	$128,769
Nov 12, 2025	Brian Jg Pereira Director	Open-market sale	−227,431	$2.72	$618,612
Nov 12, 2025	Brian Jg Pereira Director	Open-market sale	−27,595	$2.72	$75,058

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about ProKidney Corp.

Who is the CEO of ProKidney Corp.?

Timothy Bertram is ProKidney Corp.'s Chief Executive Officer.

How many directors are on ProKidney Corp.'s board?

ProKidney Corp.'s board has 10 directors: Alan Lotvin, Brian Jg Pereira, Bruce Culleton, Jennifer A. Fox, John Maraganore, Pablo G. Legorreta, Santos Jose Ignacio Jimenez, Timothy Bertram, Uma Sinha and William F. Doyle.

Are ProKidney Corp. insiders buying or selling shares?

Over the last 12 months, ProKidney Corp. insiders made no open-market purchases and sold $3.0 million of shares in 10 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is ProKidney Corp. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="prokidney-corp"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.